Echocardiographic validation of pulmonary hypertension due to heart failure with reduced ejection fraction in mice
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Echocardiographic validation of pulmonary hypertension due to heart failure with reduced ejection fraction in mice ; volume:8 ; number:1 ; day:22 ; month:1 ; year:2018 ; pages:1-11 ; date:12.2018
Scientific reports ; 8, Heft 1 (22.1.2018), 1-11, 12.2018
- Keyword
-
Kardiovaskuläre Krankheit
- Creator
-
Dayeh, Nour R.
- Contributor
-
Tardif, Jean-Claude
Shi, Yanfen
Tanguay, Mégane
Ledoux, Jonathan
Dupuis, Jocelyn
SpringerLink (Online service)
- DOI
-
10.1038/s41598-018-19625-2
- URN
-
urn:nbn:de:1111-201804031783
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:04 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Dayeh, Nour R.
- Tardif, Jean-Claude
- Shi, Yanfen
- Tanguay, Mégane
- Ledoux, Jonathan
- Dupuis, Jocelyn
- SpringerLink (Online service)
Other Objects (12)
Echocardiographic predictors of outcome in severe aortic stenosis patients with preserved or reduced ejection fraction
Vericiguat for Heart Failure with Reduced Ejection Fraction
SGLT2 inhibitors in heart failure with reduced ejection fraction
Heart Failure with Reduced Ejection Fraction—Does Sex Matter?
Improvement in left ventricular ejection fraction after pharmacological up-titration in new-onset heart failure with reduced ejection fraction
Right ventricular ejection fraction
Contemporary Drug Treatment of Advanced Heart Failure with Reduced Ejection Fraction
Dapagliflozin: A Review in Symptomatic Heart Failure with Reduced Ejection Fraction
Genetic architecture of heart failure with preserved versus reduced ejection fraction
Anticoagulants for stroke prevention in heart failure with reduced ejection fraction
Diagnostic value of echocardiographic markers for diastolic dysfunction and heart failure with preserved ejection fraction
Intact fibroblast growth factor 23 in heart failure with reduced and mildly reduced ejection fraction
Echocardiographic predictors of outcome in severe aortic stenosis patients with preserved or reduced ejection fraction
Vericiguat for Heart Failure with Reduced Ejection Fraction
SGLT2 inhibitors in heart failure with reduced ejection fraction
Heart Failure with Reduced Ejection Fraction—Does Sex Matter?
Improvement in left ventricular ejection fraction after pharmacological up-titration in new-onset heart failure with reduced ejection fraction
Right ventricular ejection fraction
Contemporary Drug Treatment of Advanced Heart Failure with Reduced Ejection Fraction
Dapagliflozin: A Review in Symptomatic Heart Failure with Reduced Ejection Fraction
Genetic architecture of heart failure with preserved versus reduced ejection fraction
Anticoagulants for stroke prevention in heart failure with reduced ejection fraction
Diagnostic value of echocardiographic markers for diastolic dysfunction and heart failure with preserved ejection fraction
Intact fibroblast growth factor 23 in heart failure with reduced and mildly reduced ejection fraction
Echocardiographic predictors of outcome in severe aortic stenosis patients with preserved or reduced ejection fraction
Vericiguat for Heart Failure with Reduced Ejection Fraction
SGLT2 inhibitors in heart failure with reduced ejection fraction
Heart Failure with Reduced Ejection Fraction—Does Sex Matter?
Improvement in left ventricular ejection fraction after pharmacological up-titration in new-onset heart failure with reduced ejection fraction
Right ventricular ejection fraction
Contemporary Drug Treatment of Advanced Heart Failure with Reduced Ejection Fraction
Dapagliflozin: A Review in Symptomatic Heart Failure with Reduced Ejection Fraction
Genetic architecture of heart failure with preserved versus reduced ejection fraction
Anticoagulants for stroke prevention in heart failure with reduced ejection fraction
Diagnostic value of echocardiographic markers for diastolic dysfunction and heart failure with preserved ejection fraction